These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17892356)

  • 21. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.
    Naveau S; Gaudé G; Asnacios A; Agostini H; Abella A; Barri-Ova N; Dauvois B; Prévot S; Ngo Y; Munteanu M; Balian A; Njiké-Nakseu M; Perlemuter G; Poynard T
    Hepatology; 2009 Jan; 49(1):97-105. PubMed ID: 19053048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M; Zein CO; McCullough AJ
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Laboratory data for assessment of nutrition in liver disease--with special reference to alcoholic hepatitis and nonalcoholic steatohepatitis (NASH)].
    Sugimoto M
    Rinsho Byori; 2003 Oct; Suppl 127():45-51. PubMed ID: 14653214
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
    Miele L; Forgione A; La Torre G; Vero V; Cefalo C; Racco S; Vellone VG; Vecchio FM; Gasbarrini G; Rapaccini GL; Neuman MG; Grieco A
    Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?
    Thuluvath PJ; Krok KL
    Am J Gastroenterol; 2005 Sep; 100(9):1981-3. PubMed ID: 16128942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interpretation of hypertransaminasemia].
    Othmani S; Bahri M; Bahri M
    Tunis Med; 2002 May; 80(5):236-44. PubMed ID: 12534025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?
    Thuluvath PJ; Krok KL
    Am J Gastroenterol; 2006 Jul; 101(7):1497-9. PubMed ID: 16863552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B.
    Mallet V; Dhalluin-Venier V; Roussin C; Bourliere M; Pettinelli ME; Giry C; Vallet-Pichard A; Fontaine H; Pol S
    Aliment Pharmacol Ther; 2009 Feb; 29(4):409-15. PubMed ID: 19035983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibromax-based nonalcoholic fatty liver disease in chronic obstructive pulmonary disease patients with obstructive sleep apnea: Methodological considerations.
    Monneret D
    F1000Res; 2017; 6():1669. PubMed ID: 29225775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
    Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
    Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive tools to assess liver disease.
    Patel K
    Curr Opin Gastroenterol; 2010 May; 26(3):227-33. PubMed ID: 20179592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
    Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus.
    Bril F; McPhaul MJ; Caulfield MP; Castille JM; Poynard T; Soldevila-Pico C; Clark VC; Firpi-Morell RJ; Lai J; Cusi K
    J Investig Med; 2019 Feb; 67(2):303-311. PubMed ID: 30309884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A diagnostic model to differentiate simple steatosis from nonalcoholic steatohepatitis based on the likelihood ratio form of Bayes theorem.
    Sookoian S; Castaño G; Burgueño AL; Gianotti TF; Rosselli MS; Pirola CJ
    Clin Biochem; 2009 May; 42(7-8):624-9. PubMed ID: 19071103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of liver histology in diagnosis of chronic hepatopathies].
    Schmid M
    Praxis (Bern 1994); 1998 Oct; 87(42):1397-401. PubMed ID: 9824946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.
    Yilmaz Y; Dolar E; Ulukaya E; Akgoz S; Keskin M; Kiyici M; Yerci O; Oral AY; Gul CB; Gurel S; Nak SG; Gulten M
    Med Sci Monit; 2009 Apr; 15(4):CR189-93. PubMed ID: 19333204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data.
    Poynard T; Lassailly G; Diaz E; Clement K; Caïazzo R; Tordjman J; Munteanu M; Perazzo H; Demol B; Callafe R; Pattou F; Charlotte F; Bedossa P; Mathurin P; Ratziu V;
    PLoS One; 2012; 7(3):e30325. PubMed ID: 22431959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.